Clinical Significance:
ALT/GPT is present in high concentration in liver and to a lesser extent in kidney, heart, skeletal muscle, pancreas, spleen and lung. Increased levels of ALT/GPT however is generally a result of liver disease associated with some degree of hepatic necrosis such as cirrhosis, viral or toxic hepatitis and obstructive jaundice. Characteristically ALT/GPT is generally higher than AST/GPT in acute viral or toxic hepatitis, whereas for most patients with chronic hepatic disease, ALT/GPT levels are generally lower than AST/GPT levels. Elevated ALT/GPT levels have also been found in extensive trauma and muscle disease, circulatory failure with shock, hypoxia, myocardial infarction and haemolytic disease.
Packaging Information:
| Method |
Pack Type |
Pack Size |
Product Code |
| IFCC |
Powder |
5 x 6.5 ml |
120206 |
| 5 x 20 ml |
120207 |
| 10 x 50 ml |
120208 |
| Liquixx |
R1: 4 x 24 ml; R2: 4 x 6 ml |
120903 |
| 4 x 250 ml |
120179 |